Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease

Cell Death and Differentiation

Volumn 13, Issue 9, 2006, Pages 1454-1465

  Akterin, S ^a   Cowburn, R F ^a   Miranda Vizuete, A ^a,b   Jimenez A ^a,c   Bogdanovic, N ^a   Winblad, B ^a   Cedazo Minguez, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Departamento de Biología Molecular e Ingeniería Bioquímica   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; APOPTOSIS SIGNAL REGULATING KINASE 1; CATALASE; DAXX PROTEIN; GLUTAREDOXIN 1; GLUTATHIONE; PROTEIN ANTIBODY; SOMATOMEDIN C; THIOREDOXIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NEUROTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; APOPTOSIS; BRAIN; CATALASE; CELL LINE, TUMOR; ELAFIN; GLUTAREDOXINS; GLUTATHIONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE KINASE KINASE 5; NUCLEAR PROTEINS; OXIDATION-REDUCTION; OXIDOREDUCTASES; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; THIOREDOXIN; THIOREDOXINS;

EID: 33747046123     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401818     Document Type: Article

References (40)

1. Hardy JA and Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256: 184-185
2. Huang X, Moir RD, Tanzi RE, Bush AI and Rogers JT (2004) Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. N. Y. Acad. Sci. 1012: 153-163
3. Small DH, Mok SS and Bornstein JC (2001) Alzheimer's disease and Abeta toxicity: From top to bottom. Nat. Rev. Neurosci. 2: 595-598
4. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC and Jay G (1995) The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9: 21-30
5. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K and Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am. J. Pathol. 155: 1459-1466
6. Holmgren A (2000) Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal. 2: 811-820
7. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94
8. Song JJ and Lee YJ (2003) Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem. J. 373: 845-853
9. Song JJ and Lee YJ (2003) Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization. J. Biol. Chem. 278: 47245-47252
10. Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A and Barzilai A (2001) Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the vas-phosphoinositide 3-kinase and jun n-terminal kinase pathways. J. Biol. Chem. 276: 21618-21626
11. Lovell MA, Xie C, Gabbita SP and Markesbery WR (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic. Biol. Med. 28: 418-427
12. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, Masutani H, Yodoi J, Urano Y, Nagano T and Ichijo H (2005) Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 12: 19-24
13. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH and Trojanowski JQ (2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48: 77-87
14. Asahina M, Yamada T, Yoshiyama Y and Yodoi J (1998) Expression of adult T cell leukemia-derived factor in human brain and peripheral nerve tissues. Dement. Geriatr. Cogn. Disord. 9: 181-185
15. Esiri M and Oppenheimer DR (1996) In Oppenheimer's Diagnostic Neuropathology: A Practical Manual (Oxford: Blackwell Science) pp. 51-77
16. Beach TG, Walker R and McGeer EG (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2: 420-436
17. Galvan V, Logvinova A, Sperandio S, Ichijo H and Bredesen DE (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J. Biol. Chem. 278: 13325-13332
18. Wei W, Wang X and Kusiak JW (2002) Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277: 17649-17656
19. Lovell MA, Ehmann WD, Butler SM and Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45: 1594-1601
20. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA and Freedman ML (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150: 40-44
21. Lippoldt A, Padilla CA, Gerst H, Andbjer B, Richter E, Holmgren A and Fuxe K (1995) Localization of thioredoxin in the rat brain and functional implications. J. Neurosci. 15: 6747-6756
22. Grant CM (2001) Role of the glutathione/glutaredoxin and thioredoxin systems in yeast growth and response to stress conditions. Mol. Microbiol. 39: 533-541
23. Yamagata K, Tagami M, Ikeda K, Yamori Y and Nara Y (2000) Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 284: 131-134
24. Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T, Fukuda K and Yodoi J (2000) Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun. 274: 177-182
25. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K and Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17: 2596-2606
26. Miranda-Vizuete A, Rodriguez-Ariza A, Toribio F, Holmgren A, Lopez-Barea J and Pueyo C (1996) The levels of ribonucleotide reductase, thioredoxin, glutaredoxin 1, and GSH are balanced in Escherichia coli K12. J. Biol. Chem. 271: 19099-19103
27. Garrido EO and Grant CM (2002) Role of thioredoxins in the response of Saccharomyces cerevisiae to oxidative stress induced by hydroperoxides. Mol. Microbiol. 43: 993-1003
28. Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Davignon J, Quirion R and Poirier J (1999) Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic. Biol. Med. 27: 544-553
29. Cardoso SM and Oliveira CR (2003) Glutathione cycle impairment mediates A beta-induced cell toxicity. Free Radic. Res. 37: 241-250
30. Chang HY, Nishitoh H, Yang X, Ichijo H and Baltimore D (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281: 1860-1863
31. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T and Ichijo H (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2: 222-228
32. Kim AH, Khursigara G, Sun X, Franke TF and Chao MV (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21: 893-901
33. Kenchappa RS, Diwakar L, Boyd MR and Ravindranath V (2002) Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury. J. Neurosci. 22: 8402-8410
34. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N and Yodoi J (1999) Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. U.S.A. 96: 4131-4136
35. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B and Cowburn RF (2003) Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. J. Neurochem. 87: 1152-1164
36. Ferrari A, Hoerndli F, Baechi T, Nitsch RM and Gotz J (2003) Beta-amyloid induces paired helical filament-like tau filaments in tissue culture. J. Biol. Chem. 278: 40162-40168
37. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G and Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
38. Simic G, Kostovic I, Winblad B and Bogdanovic N (1997) Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J. Comp. Neurol. 379: 482-494
39. Trotter EW and Grant CM (2003) Non-reciprocal regulation of the redox state of the glutathione-glutaredoxin and thioredoxin systems. EMBO Rep. 4: 184-188
40. Johansson LH and Borg LA (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem. 174: 331-336